Terms: = Breast cancer AND RAF1, Raf-1, 5894, P04049, ENSG00000132155, c-Raf, CRAF
267 results:
1. A rare Ewing-like small round cell tumor in prostate: a case report and literature review.
Wang Z; Ye J; Hu J; Zhang N; Yuan Y
J Cancer Res Clin Oncol; 2024 Mar; 150(3):110. PubMed ID: 38427070
[TBL] [Abstract] [Full Text] [Related]
2. The antipsychotic drug pimozide promotes apoptosis through the RAF/ERK pathway and enhances autophagy in breast cancer cells.
Jiang G; Zhou X; Hu Y; Tan X; Wang D; Yang L; Zhang Q; Liu S
Cancer Biol Ther; 2024 Dec; 25(1):2302413. PubMed ID: 38356266
[TBL] [Abstract] [Full Text] [Related]
3. Troponin T1 silencing inhibits paclitaxel resistance and the development of breast cancer via suppressing rat sarcoma virus/rapidly accelerated fibrosarcoma 1 pathway.
Zhu T; Zhou P; Yang L; Fang X; Zhi X
Environ Toxicol; 2024 Apr; 39(4):2064-2076. PubMed ID: 38095131
[TBL] [Abstract] [Full Text] [Related]
4. Plasma microRNA-195, -34c, and - 1246 as novel biomarkers for the diagnosis of trastuzumab-resistant HER2-positive breast cancer patients.
Rezaei Z; Dastjerdi K; Allahyari A; ShahidSales S; Talebian S; Maharati A; Zangooie A; Zangouei AS; Sadri F; Sargazi S
Toxicol Appl Pharmacol; 2023 Sep; 475():116652. PubMed ID: 37557922
[TBL] [Abstract] [Full Text] [Related]
5. SHOC2 mediates the drug-resistance of triple-negative breast cancer cells to everolimus.
Geng W; Cao M; Dong K; An J; Gao H
Cancer Biol Ther; 2023 Dec; 24(1):2206362. PubMed ID: 37170083
[TBL] [Abstract] [Full Text] [Related]
6. MIR497HG-Derived miR-195 and miR-497 Mediate Tamoxifen Resistance via PI3K/AKT Signaling in breast cancer.
Tian Y; Chen ZH; Wu P; Zhang D; Ma Y; Liu XF; Wang X; Ding D; Cao XC; Yu Y
Adv Sci (Weinh); 2023 Apr; 10(12):e2204819. PubMed ID: 36815359
[TBL] [Abstract] [Full Text] [Related]
7. Long-Term Simulation of Microgravity Induces Changes in Gene Expression in breast cancer Cells.
Sahana J; Cortés-Sánchez JL; Sandt V; Melnik D; Corydon TJ; Schulz H; Cai Z; Evert K; Grimm D; Wehland M
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674696
[TBL] [Abstract] [Full Text] [Related]
8. Intracellular Ellagic Acid Derived from Goat Urine DMSO Fraction (GUDF) Predicted as an Inhibitor of c-raf Kinase.
Raj AK; Lokhande KB; Prasad TK; Nandangiri R; Choudhary S; Pal JK; Sharma NK
Curr Mol Med; 2024; 24(2):264-279. PubMed ID: 36642883
[TBL] [Abstract] [Full Text] [Related]
9. Design, synthesis and anticancer activity of novel 2-arylbenzimidazole/2-thiopyrimidines and 2-thioquinazolin-4(3H)-ones conjugates as targeted RAF and VEGFR-2 kinases inhibitors.
Ali IH; Abdel-Mohsen HT; Mounier MM; Abo-Elfadl MT; El Kerdawy AM; Ghannam IAY
Bioorg Chem; 2022 Sep; 126():105883. PubMed ID: 35636123
[TBL] [Abstract] [Full Text] [Related]
10. Novel
Yeung MCF; Lam AYL; Shek TWH
Int J Surg Pathol; 2022 Sep; 30(6):682-688. PubMed ID: 35156861
[TBL] [Abstract] [Full Text] [Related]
11. A Clinical Evaluation of Circulating MiR-106a and raf-1 as breast cancer Diagnostic and Prognostic Markers.
Ahmed Mohmmed E; Shousha WG; El-Saiid AS; Ramadan SS
Asian Pac J Cancer Prev; 2021 Nov; 22(11):3513-3520. PubMed ID: 34837907
[TBL] [Abstract] [Full Text] [Related]
12. Human estrogen receptor α antagonists, part 2: Synthesis driven by rational design, in vitro antiproliferative, and in vivo anticancer evaluation of innovative coumarin-related antiestrogens as breast cancer suppressants.
Kurtanović N; Tomašević N; Matić S; Mitrović MM; Kostić DA; Sabatino M; Antonini L; Ragno R; Mladenović M
Eur J Med Chem; 2022 Jan; 227():113869. PubMed ID: 34710747
[TBL] [Abstract] [Full Text] [Related]
13. The RhoA dependent anti-metastatic function of RKIP in breast cancer.
Kalpana G; Figy C; Feng J; Tipton C; De Castro JN; Bach VN; Borile C; LaSalla A; Odeh HN; Yeung M; Garcia-Mata R; Yeung KC
Sci Rep; 2021 Aug; 11(1):17455. PubMed ID: 34465801
[TBL] [Abstract] [Full Text] [Related]
14. Patterns of Innate or Acquired Resistance to Anticancer Drugs: Our Experience to Overcome It.
Poma P; Labbozzetta M; Notarbartolo M
Crit Rev Oncog; 2021; 26(2):27-37. PubMed ID: 34347971
[TBL] [Abstract] [Full Text] [Related]
15. Formononetin relieves the facilitating effect of lncRNA AFAP1-AS1-miR-195/miR-545 axis on progression and chemo-resistance of triple-negative breast cancer.
Wu J; Xu W; Ma L; Sheng J; Ye M; Chen H; Zhang Y; Wang B; Liao M; Meng T; Zhou Y; Chen H
Aging (Albany NY); 2021 Jul; 13(14):18191-18222. PubMed ID: 34289449
[TBL] [Abstract] [Full Text] [Related]
16. Low Expression of Rasal2 Promotes Non-small Cell Lung cancer Metastasis through Ras/ERK Pathway.
Fan D; Yu S; Yang Y; Qu S
Biol Pharm Bull; 2021; 44(7):992-998. PubMed ID: 34193694
[TBL] [Abstract] [Full Text] [Related]
17. Peptide-tiling screens of cancer drivers reveal oncogenic protein domains and associated peptide inhibitors.
Ford KM; Panwala R; Chen DH; Portell A; Palmer N; Mali P
Cell Syst; 2021 Jul; 12(7):716-732.e7. PubMed ID: 34051140
[TBL] [Abstract] [Full Text] [Related]
18. Systemic review on B-Raf
Chavda J; Bhatt H
Eur J Med Chem; 2020 Nov; 206():112675. PubMed ID: 32798788
[TBL] [Abstract] [Full Text] [Related]
19. Induction of PIK3CA alterations during neoadjuvant letrozole may improve outcome in postmenopausal breast cancer patients.
Skriver SK; Jensen MB; Eriksen JO; Ahlborn LB; Knoop AS; Rossing M; Ejlertsen B; Laenkholm AV
Breast Cancer Res Treat; 2020 Nov; 184(1):123-133. PubMed ID: 32748297
[TBL] [Abstract] [Full Text] [Related]
20. Regorafenib sensitizes human breast cancer cells to radiation by inhibiting multiple kinases and inducing DNA damage.
Mehta M; Griffith J; Panneerselvam J; Babu A; Mani J; Herman T; Ramesh R; Munshi A
Int J Radiat Biol; 2021; 97(8):1109-1120. PubMed ID: 32052681
[TBL] [Abstract] [Full Text] [Related]
[Next]
